Solid Organ Transplantation Recipient clinical trials at UCSF
1 in progress, 1 open to new patients
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
open to eligible females ages 18–49
This phase II trial studies how well a nonavalent human papillomavirus vaccine works in preventing human papillomavirus-related cancer in adult women prior to living donor kidney transplantation. Vaccines made from peptides of human papillomavirus may help the body build an effective immune response to kill tumor cells. Giving booster vaccinations may make a stronger immune response and prevent or delay the recurrence of cancer.
San Francisco, California and other locations